Madison Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$129M Sell
243,502
-18,791
-7% -$8.67M 1.54% 15
2026
Q1
$126M Sell
262,293
-15,464
-6% -$7.92M 1.56% 12
2025
Q4
$156M Sell
277,757
-14,872
-5% -$8.44M 1.79% 11
2025
Q3
$150M Sell
292,629
-4,419
-1% -$1.93M 1.66% 13
2025
Q2
$93.2M Buy
297,048
+287,365
+2,968% +$86.3M 1.01% 35
2025
Q1
$2.95M Buy
9,683
+2,737
+39% +$921K 0.03% 201
2024
Q4
$2.31M Buy
+6,946
New +$2.36M 0.03% 231

Other funds holding MEDP

Madison Asset Management's MEDP Position: Q2 2026 in Review

Madison Asset Management reduced its Medpace (MEDP) stake by 7.2% in Q2 2026, selling an estimated $8.67M and leaving 243,502 shares worth $129M. The position accounts for 1.54% of the portfolio, ranked #15.

Madison Asset Management first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $156M in Q4 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Madison Asset Management held 243,502 shares of Medpace worth $129M as of Q2 2026.
  • Madison Asset Management sold 18,791 Medpace shares in Q2 2026, an estimated $8.67M.
  • Medpace made up 1.54% of Madison Asset Management's portfolio in Q2 2026, its #15 holding.
  • Madison Asset Management first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • Madison Asset Management's Medpace position peaked at $156M in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Madison Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.